Table 2.

Beta-thalassemia genotypes among 127 transfusion-dependent thalassemic patients enrolled in the current study.

	Genotype	Number (%)
	Homozygous
1	IVSII.1 (G > A)/IVSII.1 (G > A)	24 (18.9)
2	IVSI.1 (G > A)/IVSI.1 (G > A)	10 (7.9)
3	Codon 8 (−AA)/Codon 8 (−AA)	8 (6.3)
4	Codon 39 (C > T)/Codon 39 (C > T)	8 (6.3)
5	Codon 44 (−C)/Codon 44 (−C)	7 (5.5)
6	Codon 8/9 (+G)/Codon 8/9 (+G)	3 (2.4)
7	Codon 5 (−CT)/Codon 5 (−CT)	3 (2.4)
8	IVSI-110 (G > A)/IVSI.110 (G > A)	1 (0.8)
9	IVSI.5 (G > C)/IVSI.5 (G > C)	1 (0.8)
10	Codon 36/37 (−T)/Codon 36/37 (−T)	1 (0.8)
	Compound Heterozygous
11	IVSII.1 (G > A)/IVSI.1 (G > A)	9 (7.1)
12	IVSI.1 (G > A)/Codon 8/9 (+G)	7 (5.5)
13	IVSI.1 (G > A)/IVSI.6 (T > C)	3 (2.4)
14	IVSII.1 (G > A)/Codon 8/9 (+G)	3 (2.4)
15	IVSII.1 (G > A)/Codon 8 (−AA)	3 (2.4)
16	Codon 8/9 (+G)/Codon 5 (−CT)	3 (2.4)
17	Codon 44 (−C)/codon 5 (−CT)	3 (2.4)
18	IVSI.1 (G > A)/Codon 8 (−AA)	2 (1.6)
19	IVSII.1 (G > A)/Codon 39 (C > T)	2 (1.6)
20	IVSII.1 (G > A)/Codon 5 (−CT)	2 (1.6)
21	Codon 39 (C > T)/codon 44 (−C)	2 (1.6)
22	IVSII.1 (G > A)/IVSI.6 (T > C)	2 (1.6)
23	IVS.I.5 (G > C)/codon 8/9 (+G)	2 (1.6)
24	IVSII.1 (G > A)/IVSI.110 (G > A)	1 (0.8)
25	Codon 5 (−CT)/Codon 8 (−AA)	1 (0.8)
26	IVSI.1 (G > A)/Codon 39 (C > T)	1 (0.8)
27	IVSII.1 (G > A)/IVSII.745 (C > G)	1 (0.8)
28	IVSI.1 (G > A)/codon 22 (−7 bp)	1 (0.8)
29	IVSII.1 (G > A)/codon 30 (G > C)	1 (0.8)
30	IVSI.5 (G > C)/codon 8 (−AA)	1 (0.8)
31	IVSI.5 (G > C)/codon 44 (−C)	1 (0.8)
32	Codon 39 (C > T)/codon 5 (−CT)	1 (0.8)
33	Codon 39(C > T)/Codon 8/9 (+G)	1 (0.8)
34	Codon 44 (−C)/codon 8/9 (+G)	1 (0.8)
35	IVSI.1/Uncharacterized	2 (1.6)
36	IVS1.6/Uncharacterized	1 (0.8)
37	IVSII.1/Uncharacterized	1 (0.8)
38	Uncharacterized/Uncharacterized	3 (2.4)
	Total	127 (100)